Pascal Leclair earned a B.Sc. in Biology and a M.Sc. in Cell and Developmental Biology from the University of British Columbia, where he is currently a research technician. One of his projects involves elucidating the mechanism of action of caspase-independent cell death following ligation of the cell-surface molecule, CD47; he is also part of the BRAvE initiative at BC Children’s Hospital Research Institute in Vancouver, which is developing a precision medicine approach to inform better treatment for children who relapse from cancer. He is an avid reader and loves music; Pascal lives in near Vancouver, BC, with his wife and twin boys.